Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to phase 3 licensure-enabling studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.


TSX:ONC - Post by User

Comment by Quentin30on Feb 07, 2024 3:54pm
64 Views
Post# 35868301

RE:RE:RE:RE:RE:Oncy is a Cult Pt. 2

RE:RE:RE:RE:RE:Oncy is a Cult Pt. 2Treating an erstwhile underserved racial group has nothing to do with rascism you twerk. The fact that african americans have massively higher rates of Sickle Cell disease compared to other ethnicities in the US is solely due to their heritage, as yoiu must well know. It's a genetic mutation that prevented premature death whilst causing other issues. Saud Arabia, where Casgevy is also approved, also has high incidence of the condition. I think they'll be able to pay..!

Claiming this to be some kind of rascist commentary is infantile. Why on earth do you think CFDA wanted AN to run a bridging study in Chinese patients.

you really are a sad little man.  
<< Previous
Bullboard Posts
Next >>